Researchers from Northwestern and the University of North Carolina at Chapel Hill developed a wireless fetal-monitoring device for pregnant people.
The wearable sensors equipped with a small rechargeable battery monitor the pregnant person and baby’s vital signs. They also provide information that can’t be gathered with existing technology, specifically the pregnant person’s movements and positions while in labor, according to a University release.
For decades, pregnant people were restrained to their beds as a result of being connected to wires to monitor their health. They were also confined by having to wear fetal-monitoring belts that often shifted out of place and needed regular adjustments.
American Skin Association Announces Research Achievement Awards
AMY S. PALLER, MD 2021 RECIPIENT OF DAVID MARTIN CARTER MENTOR AWARD
News provided by
Share this article
Share this article
2021 David Martin Carter Mentor Award and the
2021 Research Achievement Awards.
For over three decades, ASA s
David Martin Carter Mentor Award has honored members of the dermatology community who embody the characteristics that made the late Dr. David Martin Carter an inspiration to dermatologists, investigators, and medical students throughout the world. Dr. Carter and ASA s late founder, Dr. George Hambrick, worked tirelessly to grow the organization into a leading force to defeat melanoma, skin cancer and other skin diseases.
May 3, 2021 at 6:47 PM
CLARK, NJ - At almost every high school graduation, both locally and nationally, a series of speakers will deliver inspiring speeches in hopes that some graduates will rise to the occasion. Class of 2010 graduate, Emily Vargas, certainly fulfilled that charge.
Upon graduating from ALJ, Vargas attended Rutgers University as a student-athlete. “I was tremendously fortunate to have received a significant track and field scholarship, which gave me the opportunity to pursue higher education,” explained Vargas, “In my four years at Rutgers, I was very busy studying and traveling around the country competing in the high jump, long jump, triple jump, and the 55-meter hurdles. The life of a student-athlete was demanding, both physically and psychologically, but it was all worth it.”
Rhythm Therapeutics, Inc. Awarded $3.67 million NIH SBIR Fast Track Grant to Develop Gene Therapy for Atrial Fibrillation
Share Article
Chicago-based Rhythm Therapeutics is led by founder Dr. Rishi Arora, Professor of Medicine, Clinical Cardiac Electrophysiology at Northwestern University - The Feinberg School of Medicine; Grant is from the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, and from the Small Business Innovation Research program that can total up to $3.67 million; Atrial fibrillation is the most common heart rhythm disorder, affecting six million people in the U.S. and 33 million worldwide.
Rishi Arora, MD, FHRS, FAHA
Opinion | We stand in solidarity with our Northwestern colleagues dailynorthwestern.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailynorthwestern.com Daily Mail and Mail on Sunday newspapers.